This 5% Dividend Stock Pays Cash Every Month

This dividend stock is one of the best options out there for long-term investors. While the yield isn’t the highest, its long-term outlook is more than promising.

| More on:

Investing in monthly dividend stocks can be a savvy strategy for those seeking a steady income stream. Unlike quarterly or annual dividends, monthly payouts provide regular cash flow. This can be particularly beneficial for budgeting and managing expenses. The consistent income can help investors meet their financial goals more predictably, making monthly dividend stocks an attractive option for income-focused portfolios.

Man data analyze

Image source: Getty Images

Consider Extendicare

One such stock to consider is Extendicare (TSX:EXE), a leading provider of senior care services in Canada. Extendicare has a strong presence in the long-term care and home healthcare sectors, operating numerous facilities and offering a range of services across the country. This established position in a growing industry makes EXE a compelling dividend stock for investors seeking reliable monthly dividends.

In its recent financial performance, Extendicare reported robust third-quarter results for 2024. The dividend stock experienced a 10.2% year-over-year increase in average daily volume in the home healthcare segment, indicating strong demand and successful recruitment and retention programs.

Looking ahead, Extendicare’s future outlook appears promising. The dividend stock is actively pursuing long-term care redevelopment projects, with six homes under construction in Ontario and plans for additional projects, enhancing future growth potential. Furthermore, Extendicare established a new $275 million senior secured credit facility, providing additional flexibility for growth and capital allocation. These initiatives demonstrate the dividend stock’s commitment to expanding its services and improving its financial position. And this bodes well for sustaining and potentially increasing dividend payouts.

Looking ahead

Investors should also note Extendicare’s commitment to returning value to shareholders through dividends. The dividend stock has consistently declared monthly dividends, with a recent announcement of a cash dividend of $0.04 per common share for December 2024. This ongoing commitment to dividend payments underscores Extendicare’s financial stability and its dedication to providing shareholders with regular income.

Furthermore, Extendicare’s strategic acquisitions and partnerships have strengthened its market position. The completion of transactions with Revera and Axium has expanded its managed services and increased the number of beds under management. These strategic moves have not only enhanced revenue streams. These also positioned the dividend stock for continued growth in the evolving healthcare sector.

It’s also worth mentioning that Extendicare’s operations are supported by favourable demographic trends. As Canada’s population ages, the demand for senior care services is expected to rise, providing a tailwind for companies like Extendicare. This demographic shift suggests a growing market for the company’s services. This could translate into sustained revenue growth and, by extension, reliable dividend payments, making Extendicare not just a dividend stock that pays now but one that should continue growing for decades to come.

Bottom line

Monthly dividend stocks offer investors the advantage of regular income, aiding in financial planning and stability. Among them, Extendicare stock stands out as a strong candidate in this category, given its solid financial performance, strategic growth initiatives, and commitment to shareholder returns. As always, potential investors should conduct their own due diligence and consider their individual financial circumstances before making investment decisions. But this dividend stock looks like one long-term investment most investors won’t regret.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Dividend Stocks

dividend stocks are a good way to earn passive income
Dividend Stocks

Invest $30,000 in 3 TSX Stocks and Create $1,262 in Dividend Income

Investing $30,000 in high-quality dividend stocks can provide a reliable stream of income regardless of short-term market movements.

Read more »

Person holding a smartphone with a stock chart on screen
Dividend Stocks

Should You Buy Telus Stock at $18?

Telus stock is trading at $18, raising questions about its dividend, valuation, and long‑term upside for Canadian investors.

Read more »

up arrow on wooden blocks
Dividend Stocks

3 Must-Own Blue-Chip Dividend Stocks for Canadians

Blue-chip dividend stocks like the 5.3%-yielding Enbridge stock make resilient additions to your portfolio for strong long-term returns.

Read more »

pig shows concept of sustainable investing
Dividend Stocks

TFSA: 3 Canadian Stocks That Are Perfection With a $7,000 TFSA Investment

These three stocks offer a balanced TFSA portfolio with reliable income and long-term growth potential.

Read more »

hand stacking money coins
Dividend Stocks

Passive Income: How Much Do You Need to Invest to Make $1,000 Per Month?

Want to generate passive income? Learn how three top Canadian dividend stocks can help you generate $1,000 per month.

Read more »

boy in bowtie and glasses gives positive thumbs up
Dividend Stocks

Build Enduring Wealth With These Canadian Blue-Chip Stocks

Looking for low-risk, defensive stocks that still have upside? These three Canadian blue-chip stocks are some of the best in…

Read more »

woman looks at iPhone
Dividend Stocks

Should You Buy BCE Stock for Its 5%-Yielding Dividend?

BCE stock offers an appealing yield of 5% and is focusing on reducing debt, adding high-quality customers, and diversifying its…

Read more »

Financial analyst reviews numbers and charts on a screen
Dividend Stocks

The 1 Canadian Dividend Stock I’d Hold Through Any Storm

Fortis (TSX:FTS) is a fantastic low-beta dividend payer with rock-solid growth prospects over the next few years.

Read more »